Timothy A. Springer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Timothy A. Springer has a total of 392 co-authors. Here are the top co-authors by number of shared publications:
Jing Li
Program in Cellular and Molecular Medicine Boston Children's Hospital Boston MA 02115 USA
17 shared publications- Aiping Jiang
Broad Institute of MIT and Harvard, Cambridge, MA, USA
16 shared publications Xianchi Dong
Program in Cellular and Molecular Medicine, Children’s Hospital Boston, and Departments of Biological Chemistry and Molecular Pharmacology and of Medicine, Harvard Medical School, Boston, USA
15 shared publicationsChafen Lu
Program in Cellular and Molecular Medicine, Children’s Hospital Boston, and Departments of Biological Chemistry and Molecular Pharmacology and of Medicine, Harvard Medical School
14 shared publicationsYan Qin
11 shared publicationsJiabin Yan
Boston Children’s Hospital
8 shared publications
Latest Publications
- Open Access
Intercellular trafficking of latent TGF-β1 converts integrin expressing cells into signaling relays
TGF-β1 is secreted as a latent complex tethered to the cell surface by milieu molecules such as GARP, and its activation requires direct engagement by integrin-expressing cells. How this interaction converts the latent complex into signaling-competent growth factor (GF) remains unclear. Here we show that contact between GARP/TGF-β1-presenting cells and cells expressing integrin αVβ6 or αVβ8 triggers rapid trogocytosis of the latent complex, both in transfected cells and two cancer cell lines that natively express these integrins. Independent labeling of the prodomain, GF, and GARP shows that all three components are co-transferred to the integrin-expressing cell, and a TGF-β1 mutant (RGE) that cannot bind integrins shows little transfer. Using a reporter system that tracks pathway activation in presenting, integrin-expressing, and bystander cells, we find that GF-neutralizing antibodies block downstream signaling more effectively in bystander cells than in the first two cell types that participate in trogocytosis. Blocking cleavage between the prodomain and the GF blocks signaling in bystander cells while still permitting signaling in trogocytosing cell types. Finally, we integrin-expressing cells that have taken up latent TGF-β1 by trogocytosis can activate it and signal to bystander cells after the TGF-β1 cells are removed, indicating that trogocytosis converts integrin-expressing cells into TGF-β signaling relays. These findings identify a role for trogocytosis in regulating the specificity of TGF-β1 activation and signaling, and reveal a novel function of integrins in controlling protein localization.
Open AccessIntercellular trafficking of latent TGF-β1 converts integrin expressing cells into signaling relays
TGF-β1 is secreted as a latent complex tethered to the cell surface by milieu molecules such as GARP, and its activation requires direct engagement by integrin-expressing cells. How this interaction converts the latent complex into signaling-competent growth factor (GF) remains unclear. Here we show that contact between GARP/TGF-β1-presenting cells and cells expressing integrin αVβ6 or αVβ8 triggers rapid trogocytosis of the latent complex, both in transfected cells and two cancer cell lines that natively express these integrins. Independent labeling of the prodomain, GF, and GARP shows that all three components are co-transferred to the integrin-expressing cell, and a TGF-β1 mutant (RGE) that cannot bind integrins shows little transfer. Using a reporter system that tracks pathway activation in presenting, integrin-expressing, and bystander cells, we find that GF-neutralizing antibodies block downstream signaling more effectively in bystander cells than in the first two cell types that participate in trogocytosis. Blocking cleavage between the prodomain and the GF blocks signaling in bystander cells while still permitting signaling in trogocytosing cell types. Finally, we integrin-expressing cells that have taken up latent TGF-β1 by trogocytosis can activate it and signal to bystander cells after the TGF-β1 cells are removed, indicating that trogocytosis converts integrin-expressing cells into TGF-β signaling relays. These findings identify a role for trogocytosis in regulating the specificity of TGF-β1 activation and signaling, and reveal a novel function of integrins in controlling protein localization.
- Open Access
Conformational Preference Classification of Integrin-Binding Ligands Using Free Energy Perturbation
Integrins are crucial cell adhesion receptors and attractive therapeutic targets, but developing safe small-molecule inhibitors has been challenging, at least in part due to inadvertent partial agonism caused by stabilization of the integrin’s open, high-affinity state. To address this challenge, we present a computational approach using Absolute Binding Free Energy Perturbation (AB-FEP) calculations to predict whether a ligand will stabilize the open or closed integrin states, leveraging the difference between the ligand’s binding free energy to the respective end states. Despite challenges posed by Ca and Mg ions, metal-coordinating residues in the binding pocket, and the subtlety of structural differences between states, AB-FEP achieved excellent classification performance on a set of known opening and closing ligands, significantly outperforming docking scores and MM-GBSA results. We also showed a good correlation between AB-FEP binding free energy differences and experimental values. Furthermore, AB-FEP provided insights into intermediate integrin states and analysis of simulation trajectories confirmed the formation of a water-mediated hydrogen bond network with an ion in the binding pocket to be characteristic for closing ligands. This work demonstrates AB-FEP as a robust method for classifying integrin ligands by the conformation they stabilize and for understanding their functional mechanisms, offering valuable guidance for designing safe and conformationally selective integrin therapeutics. TOC Graphic:
Open AccessConformational Preference Classification of Integrin-Binding Ligands Using Free Energy Perturbation
Integrins are crucial cell adhesion receptors and attractive therapeutic targets, but developing safe small-molecule inhibitors has been challenging, at least in part due to inadvertent partial agonism caused by stabilization of the integrin’s open, high-affinity state. To address this challenge, we present a computational approach using Absolute Binding Free Energy Perturbation (AB-FEP) calculations to predict whether a ligand will stabilize the open or closed integrin states, leveraging the difference between the ligand’s binding free energy to the respective end states. Despite challenges posed by Ca and Mg ions, metal-coordinating residues in the binding pocket, and the subtlety of structural differences between states, AB-FEP achieved excellent classification performance on a set of known opening and closing ligands, significantly outperforming docking scores and MM-GBSA results. We also showed a good correlation between AB-FEP binding free energy differences and experimental values. Furthermore, AB-FEP provided insights into intermediate integrin states and analysis of simulation trajectories confirmed the formation of a water-mediated hydrogen bond network with an ion in the binding pocket to be characteristic for closing ligands. This work demonstrates AB-FEP as a robust method for classifying integrin ligands by the conformation they stabilize and for understanding their functional mechanisms, offering valuable guidance for designing safe and conformationally selective integrin therapeutics. TOC Graphic:
- Open Access
- 13 March 2026
- Published by Springer Nature in Research Square
Conformational landscape of integrin α4β1 and its recognition of VCAM and conformation-stabilizing small molecules
Integrin α4β1 recognition of vascular cell adhesion molecule (VCAM) is essential for leukocyte adhesion, migration, and signaling, yet is structurally unresolved. Here, we report cryo-electron microscopy (cryo-EM) structures of human α4β1 in apo closed conformations and in an open conformation bound to conformation-specific antibody fragment 12G10, alone or together with VCAM domains 1-3 or 4-6. The homologous D1 and D4 domains recognize α4β1 with comparable affinity, inserting lengthwise between the α4 propeller and β1 βI domains. The VCAM loop that binds the integrin metal ion-dependent adhesion site (MIDAS) flips its backbone and Asp sidechain to coordinate the MIDAS Mg2+ ion. Crystal structures of α4β1 with small-molecule stabilizers of closed or open states reveal a novel closure-stabilizing motif and diverse binding modes, including to α/β interfaces outside the VCAM binding pocket. We define the mechanism of α4β1 activation and ligand recognition, providing a framework for the rational design of immunomodulatory therapeutics.
- 13 March 2026
- Published by Springer Nature in Research Square
Open AccessConformational landscape of integrin α4β1 and its recognition of VCAM and conformation-stabilizing small molecules
Integrin α4β1 recognition of vascular cell adhesion molecule (VCAM) is essential for leukocyte adhesion, migration, and signaling, yet is structurally unresolved. Here, we report cryo-electron microscopy (cryo-EM) structures of human α4β1 in apo closed conformations and in an open conformation bound to conformation-specific antibody fragment 12G10, alone or together with VCAM domains 1-3 or 4-6. The homologous D1 and D4 domains recognize α4β1 with comparable affinity, inserting lengthwise between the α4 propeller and β1 βI domains. The VCAM loop that binds the integrin metal ion-dependent adhesion site (MIDAS) flips its backbone and Asp sidechain to coordinate the MIDAS Mg2+ ion. Crystal structures of α4β1 with small-molecule stabilizers of closed or open states reveal a novel closure-stabilizing motif and diverse binding modes, including to α/β interfaces outside the VCAM binding pocket. We define the mechanism of α4β1 activation and ligand recognition, providing a framework for the rational design of immunomodulatory therapeutics.
- Open Access
- 28 October 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (10) , 1-11
A single-chain derivative of an integrin-activating antibody potentiates organoid growth in Matrigel and collagen hydrogels
Current methods of culturing human epithelial organoids from adult stem cells may not be compatible with clinical applications as they rely on xenogeneic, chemically undefined or non-standardized components such as the basement membrane extract Matrigel. Matrigel provides a source of extracellular matrix molecules, including laminins and collagen IV, which interact with β1 integrins expressed on organoid cells. Here we describe a single-chain (sc) version of antibody TS2/16 that allosterically activates integrin β1 function in organoids. The addition of monomeric scTS2/16 to organoid medium results in up to a fivefold increase in the yield of all gastrointestinal organoids grown in Matrigel. Moreover, scTS2/16 supports a six- to sevenfold increase in the yield of these organoids when cultured in collagen I hydrogels, both in 3D and 2D. Collagen I is well defined, available in clinical-grade formulations and, when combined with scTS2/16, may support the clinical application of epithelial organoids derived from gastrointestinal tissues and other epithelial sources.
- 28 October 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (10) , 1-11
Open AccessA single-chain derivative of an integrin-activating antibody potentiates organoid growth in Matrigel and collagen hydrogels
Current methods of culturing human epithelial organoids from adult stem cells may not be compatible with clinical applications as they rely on xenogeneic, chemically undefined or non-standardized components such as the basement membrane extract Matrigel. Matrigel provides a source of extracellular matrix molecules, including laminins and collagen IV, which interact with β1 integrins expressed on organoid cells. Here we describe a single-chain (sc) version of antibody TS2/16 that allosterically activates integrin β1 function in organoids. The addition of monomeric scTS2/16 to organoid medium results in up to a fivefold increase in the yield of all gastrointestinal organoids grown in Matrigel. Moreover, scTS2/16 supports a six- to sevenfold increase in the yield of these organoids when cultured in collagen I hydrogels, both in 3D and 2D. Collagen I is well defined, available in clinical-grade formulations and, when combined with scTS2/16, may support the clinical application of epithelial organoids derived from gastrointestinal tissues and other epithelial sources.
- Open Access
- 12 June 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (7) , 110374
Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations
- 12 June 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (7) , 110374
Open AccessNanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations
- Open Access
- 9 June 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (34) , e2500872
De Novo Design of Integrin α5β1 Modulating Proteins to Enhance Biomaterial Properties
Integrin α5β1 is crucial for cell attachment and migration in development and tissue regeneration, and α5β1 binding proteins can have considerable utility in regenerative medicine and next‐generation therapeutics. We use computational protein design to create de novo α5β1‐specific modulating miniprotein binders, called NeoNectins, that bind to and stabilize the open state of α5β1. When immobilized onto titanium surfaces and throughout 3D hydrogels, the NeoNectins outperform native fibronectin (FN) and RGD peptides in enhancing cell attachment and spreading, and NeoNectin‐grafted titanium implants outperformed FN‐ and RGD‐grafted implants in animal models in promoting tissue integration and bone growth. NeoNectins should be broadly applicable for tissue engineering and biomedicine.
- 9 June 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (34) , e2500872
Open AccessDe Novo Design of Integrin α5β1 Modulating Proteins to Enhance Biomaterial Properties
Integrin α5β1 is crucial for cell attachment and migration in development and tissue regeneration, and α5β1 binding proteins can have considerable utility in regenerative medicine and next‐generation therapeutics. We use computational protein design to create de novo α5β1‐specific modulating miniprotein binders, called NeoNectins, that bind to and stabilize the open state of α5β1. When immobilized onto titanium surfaces and throughout 3D hydrogels, the NeoNectins outperform native fibronectin (FN) and RGD peptides in enhancing cell attachment and spreading, and NeoNectin‐grafted titanium implants outperformed FN‐ and RGD‐grafted implants in animal models in promoting tissue integration and bone growth. NeoNectins should be broadly applicable for tissue engineering and biomedicine.
- Open Access
High-Throughput Machine Learning-Aided Antibody Discovery for Cell Surface Antigens
Machine learning (ML) has the potential to revolutionize antibody design and selection, but its success depends on access to extensive, well-curated datasets of antibody-antigen interactions. To address this need, we developed a synthetic Fab yeast display library optimized for seamless ML integration, focusing on sequence diversity within the CDRH3 loop. The library incorporates key sequence features derived from human B cell repertoires essential for efficient antibody generation captured in a compact antigen recognition module (ARM) format. Built using the VH1-69 heavy chain and four light chains, the library was evaluated against ten human and murine cell surface antigens, including PD-L1, TIGIT, and ROBO1. This approach yielded hundreds of antibodies with robust biophysical properties, validated for functional performance in flow cytometry and immunohistochemistry. Furthermore, ML analysis identified additional antibodies for ROBO2 and PD-L2 from the aggregate sequencing data, demonstrating utility for hybrid in silico and experimental workflows. We provide a publicly accessible dataset comprising more than 68,000 Fab sequences and 486 characterized antibodies. This study establishes an ML-compatible framework designed to accelerate and streamline antibody discovery and development.
Open AccessHigh-Throughput Machine Learning-Aided Antibody Discovery for Cell Surface Antigens
Machine learning (ML) has the potential to revolutionize antibody design and selection, but its success depends on access to extensive, well-curated datasets of antibody-antigen interactions. To address this need, we developed a synthetic Fab yeast display library optimized for seamless ML integration, focusing on sequence diversity within the CDRH3 loop. The library incorporates key sequence features derived from human B cell repertoires essential for efficient antibody generation captured in a compact antigen recognition module (ARM) format. Built using the VH1-69 heavy chain and four light chains, the library was evaluated against ten human and murine cell surface antigens, including PD-L1, TIGIT, and ROBO1. This approach yielded hundreds of antibodies with robust biophysical properties, validated for functional performance in flow cytometry and immunohistochemistry. Furthermore, ML analysis identified additional antibodies for ROBO2 and PD-L2 from the aggregate sequencing data, demonstrating utility for hybrid in silico and experimental workflows. We provide a publicly accessible dataset comprising more than 68,000 Fab sequences and 486 characterized antibodies. This study establishes an ML-compatible framework designed to accelerate and streamline antibody discovery and development.
- Open Access
De Novo Design of Integrin α5β1 Modulating Proteins for Regenerative Medicine
Integrin α5β1 is crucial for cell attachment and migration in development and tissue regeneration, and α5β1 binding proteins could have considerable utility in regenerative medicine and next-generation therapeutics. We use computational protein design to create de novo α5β1-specific modulating miniprotein binders, called NeoNectins, that bind to and stabilize the open state of α5β1. When immobilized onto titanium surfaces and throughout 3D hydrogels, the NeoNectins outperform native fibronectin and RGD peptide in enhancing cell attachment and spreading, and NeoNectin-coated titanium implants outperformed fibronectin and RGD-coated implants in animal models in promoting tissue integration and bone growth. NeoNectins should be broadly applicable for tissue engineering and biomedicine. One-Sentence Summary A de novo-designed fibronectin substitute, NeoNectin, is specific for integrin α5β1 and can be incorporated into biomaterials for regenerative medicine.
Open AccessDe Novo Design of Integrin α5β1 Modulating Proteins for Regenerative Medicine
Integrin α5β1 is crucial for cell attachment and migration in development and tissue regeneration, and α5β1 binding proteins could have considerable utility in regenerative medicine and next-generation therapeutics. We use computational protein design to create de novo α5β1-specific modulating miniprotein binders, called NeoNectins, that bind to and stabilize the open state of α5β1. When immobilized onto titanium surfaces and throughout 3D hydrogels, the NeoNectins outperform native fibronectin and RGD peptide in enhancing cell attachment and spreading, and NeoNectin-coated titanium implants outperformed fibronectin and RGD-coated implants in animal models in promoting tissue integration and bone growth. NeoNectins should be broadly applicable for tissue engineering and biomedicine. One-Sentence Summary A de novo-designed fibronectin substitute, NeoNectin, is specific for integrin α5β1 and can be incorporated into biomaterials for regenerative medicine.
- Open Access
- 18 June 2024
- Published by Taylor & Francis in mAbs
- Vol. 16 (1) , 2365891
Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits
Integrins are cell surface receptors that mediate the interactions of cells with their surroundings and play essential roles in cell adhesion, migration, and homeostasis. Eight of the 24 integrins bind to the tripeptide Arg-Gly-Asp (RGD) motif in their extracellular ligands, comprising the RGD-binding integrin subfamily. Despite similarity in recognizing the RGD motif and some redundancy, these integrins can selectively recognize RGD-containing ligands to fulfill specific functions in cellular processes. Antibodies against individual RGD-binding integrins are desirable for investigating their specific functions, and were selected here from a synthetic yeast-displayed Fab library. We discovered 11 antibodies that exhibit high specificity and affinity toward their target integrins, i.e. αVβ3, αVβ5, αVβ6, αVβ8, and α5β1. Of these, six are function-blocking antibodies and contain a ligand-mimetic R(G/L/T)D motif in their CDR3 sequences. We report antibody-binding specificity, kinetics, and binding affinity for purified integrin ectodomains, as well as intact integrins on the cell surface. We further used these antibodies to reveal binding preferences of the αV subunit for its 5 β-subunit partners: β6 = β8 > β3 > β1 = β5.
- 18 June 2024
- Published by Taylor & Francis in mAbs
- Vol. 16 (1) , 2365891
Open AccessSynthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits
Integrins are cell surface receptors that mediate the interactions of cells with their surroundings and play essential roles in cell adhesion, migration, and homeostasis. Eight of the 24 integrins bind to the tripeptide Arg-Gly-Asp (RGD) motif in their extracellular ligands, comprising the RGD-binding integrin subfamily. Despite similarity in recognizing the RGD motif and some redundancy, these integrins can selectively recognize RGD-containing ligands to fulfill specific functions in cellular processes. Antibodies against individual RGD-binding integrins are desirable for investigating their specific functions, and were selected here from a synthetic yeast-displayed Fab library. We discovered 11 antibodies that exhibit high specificity and affinity toward their target integrins, i.e. αVβ3, αVβ5, αVβ6, αVβ8, and α5β1. Of these, six are function-blocking antibodies and contain a ligand-mimetic R(G/L/T)D motif in their CDR3 sequences. We report antibody-binding specificity, kinetics, and binding affinity for purified integrin ectodomains, as well as intact integrins on the cell surface. We further used these antibodies to reveal binding preferences of the αV subunit for its 5 β-subunit partners: β6 = β8 > β3 > β1 = β5.
- Top Cited PapersOpen Access
Ligand binding initiates single-molecule integrin conformational activation
Top Cited PapersOpen AccessLigand binding initiates single-molecule integrin conformational activation